A randomized controlled trial for Shugan Tiaoshen integrated program of acupuncture and moxibustion in the treatment of moderate depressive disorder
- Conditions
- Depressive disorder
- Registration Number
- ITMCTR2100004351
- Lead Sponsor
- Guangdong Hospital of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. The results were in accordance with the diagnostic criteria of traditional Chinese and Western medicine;
2. Age 18-65 years old, junior high school or above;
3. The 17 item Hamilton Depression Scale (HAMD-17) scores were more than 17 and less than 24;
4. They signed informed consent and volunteered to participate in this study.
Only those who meet the above 4 items can be included in the study.
1. Those with suicidal tendency;
2. Previous diagnosis of mental retardation, schizophrenia, bipolar disorder, substance abuse (such as alcohol dependence) or other mental disorders;
3. History of epilepsy, family history of strong positive epilepsy, history of brain organic diseases and severe somatic diseases;
4. Those who are taking antidepressants within 6 weeks (including 6 weeks);
5. Pregnancy, pregnancy preparation or lactation;
6. Patients with skin lesions or skin diseases, severe diabetes mellitus, tumor and important organ dysfunction, or severe internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory and hematopoietic systems;
Those who met any of the above criteria were excluded from the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HAMD-17;
- Secondary Outcome Measures
Name Time Method PSQI;Actigraphy;PHQ-9;HAMA;